Sale of BASF Textile Chemicals to Archroma Completed

Along with the official launch of the new Ineos-Solvay PVC joint venture Inovyn and BASF’s sale of its 25% stake in SolVin, another PVC jv, to Solvay, BASF has completed the sale of its textile chemicals business to Archroma.

The BASF business strategically complements its own portfolio and geographical presence and further solidifies its position as a clear industry leader in supplying chemicals and dyes to the global textile industry, said Archroma.

In 2014, the carve-out from Swiss specialty chemicals producer Clariant, currently owned by private equity investor SK Capital Partners acquired a stake in textile dyes and chemicals manufacturer M. Dohmen.

With the latest deal, the Swiss company said it will be able to build on BASF’s strong market positions in Asia and several other high-growth markets.

“The operational and intellectual synergies between BASF and Archroma will allow us to offer our customers the full breadth and depth of innovation, quality, reliability, expertise and market coverage they need,” said CEO Alexander Wessels.

Around 225 BASF employees, including 175 based in Asia, will transfer to the business. The combined textiles businesses will remain headquartered in Singapore.

The transfer of Karachi-based BASF Pakistan to Archroma is expected to take place in August of this year.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.